Ensifentrine (Ensifentrinum) is a PDE3/4 inhibitor, although its affinity for PDE3(IC50: 0.4 nM) is 3,440 times higher than that for PDE4(IC50: 1479 nM), that is under clinical development for the treatment of asthma and COPD and, potentially, cystic fibrosis.
Molecular Weight:
477.56
Purity:
99.94%
CAS Number:
[1884461-72-6]
Formula:
C26H31N5O4
Target:
PDE
T25376
* VAT and and shipping costs not included. Errors and price changes excepted
